Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Public Health Informed Consent topic

No spam. Unsubscribe anytime.

Senator Corbin introduces COVID-19 vaccine informed-consent bill; cosponsors added

2316026 · February 13, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Senator Corbin introduced legislation requiring an informed-consent protocol prior to administration of a specified COVID-19 vaccine, saying private labs and some public reporting raised concerns; multiple senators asked to be added as cosponsors and the bill was referred to the Medical Affairs Committee.

Senator Corbin introduced a bill that would require an informed-consent protocol before a specified COVID-19 vaccine is administered or received.

On the Senate floor, Corbin said private labs and scientists had reported finding material he called "contamination" in a Pfizer COVID-19 vaccine and that the Food and Drug Administration had performed its own analysis. Corbin framed the bill as an informed-consent measure that would not prohibit vaccination but would require patients to be told certain information and to sign a form confirming they received that information before receiving the vaccine. He called the measure “simply an informed consent bill” and said, "It doesn't block you from taking it. It simply lets you know that there is contamination in there and that you should be aware of that."

Several senators asked to be added as cosponsors on the floor, and the clerk recorded cosponsor additions by unanimous consent, including senators from Anderson, Pickens, Greenwood, Charleston and Sumter. The bill was referred to the Medical Affairs Committee for further consideration.

The Senate record shows floor-level expressions of concern and calls for review, but the transcript does not provide independent evidence beyond the senators' statements about laboratory findings; the bill now moves to committee review, where staff and agency testimony and scientific evidence can be introduced and vetted.